CytoSolve

CytoSolve is a computational systems biology company developing infrastructure to model biological systems and discover multi-compound therapies and formulations. Founded on systems biology research at MIT, the platform integrates molecular pathways into unified, executable models to predict how compounds may interact, including potential synergy, toxicity, and dose-dependent effects. Unlike black-box artificial intelligence or trial-and-error approaches, CytoSolve uses mechanistic, peer-reviewed biological knowledge to generate explainable, reproducible insights without relying on animal testing for computational screening.

Its services include systems architecture development, peer-reviewed model validation, in-silico pathway modeling, ingredient analysis, large-scale combination screening, and support for government and regulatory filings. CytoSolve also helps partners translate computational discoveries into optimized formulations, intellectual property, licensing, and commercialization. The platform is designed for applications across human, animal, and plant health, as well as nutrition and agriculture. Through partnerships with researchers and organizations in pharmaceuticals, nutraceuticals, consumer products, and agriculture, CytoSolve aims to reduce the time, cost, and risk of discovering and developing new products. It also offers educational videos, symposia, and resources.